Right Ventricular Failure
1. Introduction
The right ventricle is unable to provide adequate forward flow into the pulmonary circulation at normal filling pressures, leading to systemic venous congestion with or without low cardiac output.most common cause of right heart failure is left ventricular failure.
In ICU practice, acute RV failure is a hemodynamic emergency — commonly seen in:
- Massive pulmonary embolism
- Acute RV infarction
- Severe pulmonary hypertension
- ARDS with high PEEP
- Post–cardiac surgery
- Sepsis-induced myocardial dysfunction
Understanding RV physiology is essential because the RV behaves very differently from the LV.
2. Right Ventricular Physiology
Structural Features
|
Feature |
Right Ventricle |
Left Ventricle |
|
Shape |
Crescent |
Circular |
|
Wall thickness |
3–5 mm(Thin-walled-Designed for volume handling, not pressure |
8–15 mm |
|
Pressure system |
Low pressure |
High pressure |
|
Afterload sensitivity |
VERY HIGH(Highly compliant) |
Moderate |
RV Pressure-Volume Loop
- Normal RV systolic pressure: 15–30 mmHg
- RV cannot tolerate acute rise in afterload
- Sudden increase in PVR → RV dilates → septal shift → LV collapse((D-shaped LV)
3. Pathophysiology of RV Failure
A. Afterload Increase (Most Dangerous)
Causes:
- Pulmonary embolism
- Pulmonary hypertension
- ARDS
- Hypercapnia
- Hypoxia
- High PEEP
B. RV Contractility Reduction
- Right ventricular myocardial infarction
- Sepsis-induced cardiomyopathy
- Myocarditis
- Post-cardiac surgery
C. Preload Excess
- Tricuspid regurgitation
- Aggressive fluid resuscitation
- Chronic pulmonary hypertension
4. Types of RV Failure
1. Acute RV Failure
Sudden rise in afterload.
Examples:
- Massive PE
- Acute RV infarction
- Acute severe ARDS
2. Chronic RV Failure (Cor Pulmonale)
Cor pulmonale =
➡️ Right ventricular (RV) hypertrophy ± dilatation and/or failure
➡️ Secondary to pulmonary hypertension caused by lung diseaseChronic obstructive pulmonary diseaseInterstitial lung disease
For Diagnosis
Diagnosis requires ALL 3 components:
A. Evidence of Pulmonary Disease
B. Evidence of Pulmonary Hypertension (PH)
Hemodynamic definition (Gold standard):
- Mean Pulmonary Artery Pressure (mPAP) ≥ 20 mmHg at rest
(via Right Heart Catheterization)
C. Evidence of Right Heart Involvement
- RV hypertrophy / dilatation
- Right heart failure signs
3. Acute on Chronic RV Failure
Example:
- COPD patient with chronic pulmonary hypertension develops acute PE.
These patients:
- Decompensate rapidly
- Require ICU care
- Have poor prognosis
|
Feature |
Acute RVF |
Chronic RVF |
|
Onset |
Sudden |
Gradual |
|
RV wall |
Thin |
Hypertrophied |
|
BP |
Often low |
Usually preserved |
|
Shock |
Common |
Rare (until late) |
|
Main cause |
PE, RV MI |
PH, COPD |
|
Echo |
Dilated RV, septal shift |
RVH + dilation |
|
Treatment urgency |
Emergency |
Long-term management |
5. Clinical Features
Symptoms
- Dyspnea
- Fatigue
- Abdominal fullness
- Peripheral edema/Anasarca
Signs
- Elevated JVP
- Prominent v waves (TR)
- Hepatomegaly
- Hepatojugular reflux
- S3 gallop
- Right ventricular heave
- Paradoxical pulse
- Ascites
- Hypotension (late)
In acute RV failure:
- Shock with clear lungs
ECG
- P pulmonale (RA enlargement)-lead II or V1
- Right axis deviation (> +90°)
- R/S ratio of 1 or less in lead V5 or V6, with an S wave amplitude of 7 mm or more in V5 or V6Dominant R in V1
- Incomplete/complete RBBB
Chest X-ray:
- Enlarged right descending pulmonary artery (>16 mm)
- Cardiomegaly (RV enlargement)
- Pruning of peripheral vessels
MRI is now the gold standard for measuring right ventricle volumes and function.
Labs
- RFT
- LFT
- ABG
- Lactate
Differentiating RVF from LV Failure
|
Feature |
RVF |
LV Failure |
|
JVP |
High |
Normal/slightly high |
|
Lung crepitations |
Absent |
Present |
|
PCWP |
Normal |
High |
|
Edema |
Prominent |
Late |
|
Shock lungs |
Clear |
Pulmonary edema |
6. Hemodynamics
|
Parameter |
Finding |
|
CVP |
High |
|
PCWP |
Normal or low |
|
MAP |
Low |
|
PVR |
High |
|
CO |
Reduced |
Pulmonary artery catheter:
- Elevated RAP
- Normal wedge pressure (if isolated RVF)
7. Echocardiographic Diagnostic Criteria
Structural Criteria
- RV dilatation (RV/LV end-diastolic area ratio > 1.0)
- RV basal diameter > 41 mm (apical 4-chamber view)
- D-shaped LV (septal flattening)
- RV hypertrophy(>5 mm wall thickness)
- A normal right ventricle should not be more than 2/3 the size of the left ventricle.
Functional Criteria
|
Parameter |
Diagnostic Cutoff |
|
TAPSE |
< 17 mm |
|
RV fractional area change (FAC) |
< 35% |
|
S’ velocity (TDI) |
< 9.5 cm/s |
|
RV free wall strain |
> −20% (less negative) |
|
Myocardial performance index (MPI): |
MPI increases as the isovolumic times increase and contraction times decrease. |
|
Eccentricity index |
allows for the quantitative assessment of septal flattening and distinguishes between pressure and volume overload. |
Acute RV Failure Specific Signs
- McConnell sign (acute PE)
- Severe TR
- Dilated IVC with poor collapse
Seen in:
- Pulmonary embolism
8. Diagnostic Criteria in Pulmonary Hypertension–Associated RVF
In chronic RV failure due to:
- Pulmonary hypertension
Criteria include:
- Mean pulmonary artery pressure ≥ 20 mmHg (right heart cath)
- Elevated PVR (>2 Wood units)
- RV enlargement + dysfunction on echo
- Elevated RAP
9. Management of Acute Right Ventricular Failure
Core Principle:
RV is preload dependent but afterload sensitive
Management = Balance preload + reduce afterload + improve contractility
Step 1: Optimize Preload
- Avoid fluid overload
- Small fluid bolus (250 ml) if hypovolemic
- Stop aggressive fluids
Over-resuscitation worsens septal shift.
Step 2: Reduce Afterload
A. Oxygenation
- Avoid hypoxia
- Avoid hypercapnia
B. Reduce PEEP
- Use lowest PEEP compatible with oxygenation
C. Pulmonary Vasodilators(in PAH cases)
- Inhaled nitric oxide-requires gradual withdrawal to prevent hemodynamic decompensation from rebound pulmonary hypertension.
- I.V epoprostenol(1 to 2 ng/kg/min, uptitrated as tolerated)
Step 3: Improve Contractility
Preferred Inotropes
|
Drug |
Effect |
|
Dobutamine |
First line(2–10 µg/kg/min) |
|
Milrinone |
Useful in pulmonary hypertension(0.25–0.75 µg/kg/min) |
|
Norepinephrine |
If hypotensive(0.05–1 µg/kg/min) |
Avoid pure alpha agents (increase PVR).
Step 4: Maintain Coronary Perfusion
RV perfusion occurs in systole + diastole.
Maintain MAP > 65 mmHg.
Step 5: Specific Treatment
- PE → Thrombolysis
- RV MI → Revascularization
- ARDS → Lung protective ventilation
10. Mechanical Support
In refractory RV failure:
- VA-ECMO
- RV assist device
Used in:
- Massive PE
- Post-cardiotomy RV failure
Cor Pulmonale Management
1. CORE PRINCIPLES
- Treat underlying cause (COPD, ILD, OSA, PE)
- Correct hypoxia (MOST IMPORTANT intervention)
- Optimize RV preload (avoid both overload & underfilling)
- Reduce pulmonary vasoconstriction
- Manage RV failure if decompensated
2. LONG-TERM OXYGEN THERAPY (LTOT) – Cornerstone
Indication (GOLD / ESC / BTS):
- PaO₂ ≤ 55 mmHg OR SaO₂ ≤ 88%
- PaO₂ 56–59 + polycythemia / cor pulmonale / pulmonary HTN
Prescription:
- Flow: 1–3 L/min via nasal prongs
- Target SpO₂: 88–92% (avoid hyperoxia)
- Duration: ≥15 hours/day (ideally 18–24 h)
Why critical?
- Reverses hypoxic pulmonary vasoconstriction
- ↓ pulmonary artery pressure
- Improves survival (ONLY intervention proven to do so in COPD cor pulmonale)
3. DIURETICS – For Volume Overload
When to start?
- Peripheral edema
- Raised JVP
- Congestive hepatomegaly
Drugs & Doses:
- Furosemide
- Start: 20–40 mg PO/IV
- Titrate up (can go 80–160 mg/day)
- Add:
- Spironolactone 25–50 mg/day (if resistant)
Caution:
- Overdiuresis → ↓ RV preload → ↓ cardiac output
- Electrolyte imbalance → arrhythmias
Key exam point:
Use cautiously — RV is preload dependent
4. BRONCHODILATORS (if COPD-related)
a) Beta-agonists
- Salbutamol
- Neb: 2.5–5 mg every 4–6 hr
- MDI: 100–200 mcg PRN
b) Anticholinergics
- Ipratropium
- Neb: 0.5 mg every 6–8 hr
c) LABA + LAMA (maintenance)
- Tiotropium, Formoterol combinations
Improve ventilation → ↓ hypoxia → ↓ pulmonary vasoconstriction
5. PULMONARY VASODILATORS
Not routinely used in cor pulmonale due to COPD
Why?
- Can worsen V/Q mismatch
- Cause hypoxemia
When to consider?
ONLY if:
- Severe pulmonary hypertension disproportionate to lung disease
- Specialist-guided therapy
Options:
- Sildenafil (PDE-5 inhibitor)
- Dose: 20 mg TDS
- Bosentan (Endothelin antagonist)
- Prostacyclin analogs (Iloprost)
Mainly used in:
- Pulmonary Arterial Hypertension (Group 1 PH)
REFERENCES
1. Hussain K, Mandras SA, Desai S. Right Heart Failure. [Updated 2024 Dec 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459381/
